
Eric Lim/vjoncology.com
Jan 15, 2025, 14:23
A Perspective on the MARS2 Trial, by Eric Lim
Oscar Tahuahua, Medical Oncology fellow at National Cancer Institute, shared an article by Eric Lim on X:
“A Perspective on the MARS2 Trial.
Is mesothelioma a surgical disease?
The MARS2 trial shows higher mortality and adverse events without improving survival. Risks increase outside high-volume centers, limiting benefits to specific subgroups.”
A Perspective on the MARS2 Trial.
Authors: Eric Lim, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 16, 2025, 19:45
Feb 16, 2025, 19:43
Feb 16, 2025, 19:39
Feb 16, 2025, 19:30
Feb 16, 2025, 19:10
Feb 16, 2025, 19:04
Feb 16, 2025, 18:59
Feb 16, 2025, 13:28